Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models
Urjita H. Shah, Javier González‐Maeso
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3068-3077
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Central 5-HT receptors and their function; present and future
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 160
The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects
Dasiel O. Borroto‐Escuela, Patrizia Ambrogini, Barbara Chruścicka, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1927-1927
Open Access | Times Cited: 82
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 63
Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia
Silas A. Buck, M. Quincy Erickson-Oberg, Ryan W. Logan, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3583-3591
Open Access | Times Cited: 47
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 23
Psychedelics in neuroinflammation: Mechanisms and therapeutic potential
Júnia L. de Deus, Juliana Marino Maia, Renato Nery Soriano, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111278-111278
Closed Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors
Karen J. Gregory, Cyril Goudet
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 521-569
Open Access | Times Cited: 53
The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines
Tomasz Boczek, Joanna Mackiewicz, Marta Sobolczyk, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1228-1228
Open Access | Times Cited: 44
GPCR heteromers: An overview of their classification, function and physiological relevance
Natasha C. Dale, Elizabeth K. M. Johnstone, Kevin D. G. Pfleger
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
Joshua T. Kantrowitz
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 947-959
Closed Access | Times Cited: 40
Pathophysiologic Role of Neurotransmitters in Digestive Diseases
Xiaoxu Yang, Jun Lou, Weixi Shan, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 34
Serotonin Regulation of the Prefrontal Cortex: Cognitive Relevance and the Impact of Developmental Perturbation
Derya Sargin, Ha‐Seul Jeoung, Nathalie M. Goodfellow, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3078-3093
Closed Access | Times Cited: 40
Role of neurotransmitters in schizophrenia: a comprehensive study
Videsha Bansal, Indranath Chatterjee
Kuwait Journal of Science (2021) Vol. 48, Iss. 2
Open Access | Times Cited: 28
Neural variability in three major psychiatric disorders
Wei Wei, Lihong Deng, Chunxia Qiao, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5217-5227
Closed Access | Times Cited: 9
Traversing the epigenetic landscape: DNA methylation from retina to brain in development and disease
Chunxiu Xu, Xuefei Fu, Huan Qin, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Cerebrolysin restores balance between excitatory and inhibitory amino acids in brain following concussive head injury. Superior neuroprotective effects of TiO2 nanowired drug delivery
Hari Shanker Sharma, Dafin F. Mureșanu, Seaab Sahib, et al.
Progress in brain research (2021), pp. e5-e6
Closed Access | Times Cited: 15
The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment
Allan Radaic, Daniel Martins‐de‐Souza
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 28, pp. 102222-102222
Closed Access | Times Cited: 16
Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia
Daniel H. Wolf, David Zheng, Christian G. Kohler, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1226-1232
Open Access | Times Cited: 14
Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Presynaptic 5-HT2A-mGlu2/3 Receptor–Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis
Alice Taddeucci, Guendalina Olivero, Alessandra Roggeri, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3035-3035
Open Access | Times Cited: 10
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
Licia Vellucci, Mariateresa Ciccarelli, Elisabetta Filomena Buonaguro, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1220-1220
Open Access | Times Cited: 5
G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism
Jon DelaCuesta-Barrutia, Olga Peñagarikano, Amaia M. Erdozain
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 14
Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex
Christian B. M. Poulie, Na Liu, Anders A. Jensen, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 17, pp. 9928-9949
Closed Access | Times Cited: 13
Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery
Paulina Cieślik, Joanna M. Wierońska
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8811-8811
Open Access | Times Cited: 11
Genetic polymorphism and neuroanatomical changes in schizophrenia
Mihai Gabriel Năstase, Ilinca Vlaicu, Simona Trifu
Romanian Journal of Morphology and Embryology (2022) Vol. 63, Iss. 2, pp. 307-322
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top